# reload+after+2024-01-22 16:45:03.112923
address1§Ole Maaloes Vej 3
address2§Copenhagen N
city§Copenhagen
zip§2200
country§Denmark
phone§45 70 70 52 10
website§https://galecto.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled small molecule inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung; GB2064, a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.
fullTimeEmployees§45
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Hans T. Schambye M.D., Ph.D.', 'age': 57, 'title': 'Co-Founder, President, CEO & Director', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 700135, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jonathan P. Freve CPA, CPA', 'age': 45, 'title': 'Chief Financial Officer', 'yearBorn': 1978, 'fiscalYear': 2022, 'totalPay': 604926, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ulf J. Nilsson', 'title': 'Co-Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Hakon  Leffler', 'title': 'Co-Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Prof. Tariq  Sethi M.D., B.Sc., M.A., Ph.D., FRCP', 'title': 'Co-Founder & Member of the Clinical Advisory Board - IPF', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Anders  Pedersen', 'age': 63, 'title': 'Chief Operating Officer', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 540395, 'exercisedValue': 0, 'unexercisedValue': 122251}, {'maxAge': 1, 'name': 'Mr. Garrett  Winslow Esq.', 'age': 44, 'title': 'Senior VP, General Counsel & Corporate Secretary', 'yearBorn': 1979, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.172
currency§USD
dateShortInterest§1702598400
forwardEps§-1.21
pegRatio§-0.01
exchange§NMS
quoteType§EQUITY
shortName§Galecto, Inc.
longName§Galecto, Inc.
firstTradeDateEpochUtc§1603978200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§02979a5f-1464-39f8-9850-05e5507f8b48
gmtOffSetMilliseconds§-18000000
targetHighPrice§10.0
targetLowPrice§2.0
targetMeanPrice§6.0
targetMedianPrice§6.0
recommendationMean§2.3
recommendationKey§buy
numberOfAnalystOpinions§2
quickRatio§3.614
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
